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Abstract
P-type ATPases from the P4 subfamily (P4-ATPases) are energy-dependent transporters, which are thought to establish lipid
asymmetry in eukaryotic cell membranes. Together with their Cdc50 accessory subunits, P4-ATPases couple ATP hydrolysis
to lipid transport from the exoplasmic to the cytoplasmic leaflet of plasma membranes, late Golgi membranes, and
endosomes. To gain insights into the structure and function of these important membrane pumps, robust protocols for
expression and purification are required. In this report, we present a procedure for high-yield co-expression of a yeast
flippase, the Drs2p-Cdc50p complex. After recovery of yeast membranes expressing both proteins, efficient purification was
achieved in a single step by affinity chromatography on streptavidin beads, yielding ,1–2 mg purified Drs2p-Cdc50p
complex per liter of culture. Importantly, the procedure enabled us to recover a fraction that mainly contained a 1:1
complex, which was assessed by size-exclusion chromatography and mass spectrometry. The functional properties of the
purified complex were examined, including the dependence of its catalytic cycle on specific lipids. The dephosphorylation
rate was stimulated in the simultaneous presence of the transported substrate, phosphatidylserine (PS), and the regulatory
lipid phosphatidylinositol-4-phosphate (PI4P), a phosphoinositide that plays critical roles in membrane trafficking events
from the trans-Golgi network (TGN). Likewise, overall ATP hydrolysis by the complex was critically dependent on the
simultaneous presence of PI4P and PS. We also identified a prominent role for PI4P in stabilization of the Drs2p-Cdc50p
complex towards temperature- or C12E8-induced irreversible inactivation. These results indicate that the Drs2p-Cdc50p
complex remains functional after affinity purification and that PI4P as a cofactor tightly controls its stability and catalytic
activity. This work offers appealing perspectives for detailed structural and functional characterization of the Drs2p-Cdc50p
lipid transport mechanism.
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Introduction
An essential feature of every eukaryotic cell is the asymmetric
distribution of phospholipids between the two leaflets of mem-
branes from the late secretory pathway. For instance phosphati-
dylserine (PS) is highly restricted to the inner leaflet of the plasma
membrane [1]. Inside the cell, this specific distribution is
important, because the negatively charged headgroup of PS is
for instance the target of C2 domain-containing proteins involved
in key cellular processes like protein phosphorylation or mem-
brane fusion [2,3], and more generally recruits various soluble
proteins to the membrane via their polybasic motifs [4,5,6]. PS
also affects the function of a number of transmembrane proteins
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[7]. Conversely, appearance of PS outside the cell is an early
indicator of apoptosis [8] and a signal to initiate blood clotting [9].
PS distribution is therefore regulated tightly and energy-
dependent transporters, the so-called flippases, have been postu-
lated to transfer PS (as well as other phospholipid species) from the
exoplasmic to the cytosolic leaflet of cell membranes. Recent data
have revealed that flippases are members of the P4 subfamily of P-
type ATPases (P4-ATPases) (e.g. [10] for review), a large family of
ATP-driven membrane transporters (divided in 5 subfamilies, P1
to P5) that pump various substrates across cell membranes. All P-
type ATPases share a common feature, namely the ability to form
an acid-stable phosphorylated intermediate during their transport
cycle. Although most P-type ATPases characterized to date have
been shown to transport cations across membranes, P4-ATPases
likely transport phospholipids, thereby maintaining phospholipid
asymmetry in cell membranes. Studies in yeast revealed a critical
role for P4-ATPases in various vesicular transport pathways [11].
For example, the yeast P4-ATPase Drs2p is required for budding
of clathrin-coated vesicles at the TGN [12] and for bi-directional
transport between early endosomes and the TGN [12,13,14]. To
explain the membrane trafficking defects that occur after
inactivation of P4-ATPases in yeast, several hypotheses have been
raised: P4-ATPases might serve as a platform for the recruitment
of proteins more directly involved in vesicular transport (e.g.
Gea2p [15,16]), or the P4-ATPase-catalyzed enrichment of
specific lipids (such as PS) in the cytosolic leaflet might control
the recruitment of proteins involved in vesicle formation, or the
mere imbalance in phospholipid number caused by P4-ATPase-
catalyzed lipid translocation would be directly involved in
triggering initial membrane bending and subsequent vesicle
formation – an early hypothesis supported by recent results from
the Tanaka group [17,18].
High-resolution crystal structures from most P-type ATPase
subfamilies (i.e. P1, P2, and P3) have already been obtained (e.g.
[19,20,21,22]) and they indicate a common overall domain
organization, with three cytoplasmic domains called the N-domain
(nucleotide binding), the P-domain (phosphorylation), and the A-
domain (actuator), as well as six to twelve a-helices comprising the
membrane-embedded part of the enzyme [23]. Based on sequence
alignments, the overall structure and the catalytic mechanism of
P4-ATPases are expected to resemble those of P2-ATPases [24],
and like some other P-type ATPases, P4-ATPases form hetero-
meric complexes with an additional protein subunit, in this case of
the Cdc50 family. However, despite these similar features, the
likely transport substrates of P4-ATPases (phospholipids) are very
different from those of the classical cation-translocating ATPases,
and the position of a phospholipid binding site as well as the
nature of the transport pathway remain open questions
[25,26,27,28]. Hence, detailed structural and functional informa-
tion is required to decipher the transport mechanism of P4-
ATPases.
Quantitative purification in an active form is a prerequisite for
detailed studies of any enzyme. For this purpose, the yeast Drs2p-
Cdc50p lipid flippase complex has been overexpressed in yeast.
Although previous studies described partial functional character-
ization of this purified flippase, only small amounts of Cdc50p
were found to be attached to Drs2p [29,30]. There has also been
some ambiguity about whether for purification in an active form,
the Drs2p protein should preferably be tagged at its N-terminus or
at its C-terminus [30,31], and in many instances, N-terminal and/
or C-terminal extensions of P-type ATPases have indeed been
suspected or found to have auto-inhibitory or regulatory roles
[21,32,33]. Here, we shortly reexamine the effects of tagging the
proteins at their N-terminal or C-terminal ends, and then describe
an efficient single-step procedure for purifying a stoichiometric
Drs2p-Cdc50p complex in significant amounts. Such purification
enabled us to characterize some of the functional properties of the
purified complex, namely the dependence on specific lipids of its
phosphorylation and dephosphorylation properties, its overall
ATP hydrolysis rate, and its stability.
Materials and Methods
Materials
Products for yeast and bacteria cultures were from Difco (BD
Biosciences). The Biotin probe (Avidin coupled to HRP) was from
Sigma-Aldrich, the Histidine probe (India Hisprobe-HRP) was
from Thermo Fischer Scientific, and the rabbit polyclonal
antibody directed against the large cytosplasmic insertion located
between transmembrane helices 4 and 5 of Drs2p (corresponding
to P- and N-domains) was kindly provided by Dr T. Graham [34].
Goat anti-rabbit secondary antibody coupled to HRP was from
Bio-Rad. DDM (n-dodecyl-b-D-maltopyranoside) was from Affy-
metrix (Anatrace detergents and lipids, United Kingdom), and
octaethylene glycol mono-n-dodecyl ether (C12E8) was from
Nikkol Chemical (Tokyo, Japan). POPC (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine), DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine), POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoethanolamine), POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
pho-L-serine), DMPS (1,2-dimyristoyl-sn-glycero-3-phospho-L-
serine), and PI4P were from Avanti Polar Lipids (COGER,
France). Streptavidin-Sepharose resin was from GE Healthcare.
Protino Ni2+-TED silica resin was from Macherey-Nagel (France).
YM100 ultrafiltration units were from Amicon systems (Millipore).
TSK-3000SW silica gel column was purchased from Tosoh
Biosciences (Tessenderlo, Belgium). Products for SDS-PAGE,
haloalkanes-containing gels (TGX Stain-Free Precast 4-20% Gels),
and gel filtration standards were from Bio-Rad (Marnes-la-
Coquette, France). BSA (albumin fraction V) was from Roth
Sochiel (France). [c-32P]ATP was from PerkinElmer Life Sciences
(catalog number BLU002A). Glass fiber A/E filters (1 mm porosity)
were from Pall Corporation, and cellulose GS filters (0.22 mm
porosity) were from Millipore. The EDTA-free SIGMAFAST
protease inhibitors tablets were from Sigma-Aldrich (Saint-
Quentin Fallavier, France). Most of the other chemical products
were purchased from Sigma-Aldrich. Rabbit sarcoplasmic retic-
ulum (SR) membranes were prepared as described previously [35].
Yeast strains and plasmids
The Saccharomyces cerevisiae W303.1b/GAL4 (a, leu2-3, his3-
11, trp1-1::TRP1-GAL10-GAL4, ura3-1, ade2-1, canr, cir+)
yeast strain was the same as previously described [36]. The Ddrs2
and Dcdc50 deletion mutants were created in W303.1b/GAL4
background using a loxP-HIS3-loxP cassette, as described [37].
Plasmid pYeDP60 was generously given by Denis Pompon
(LISBP, Toulouse, France). Plasmids allowing the expression of
either Bad-tagged Drs2p or His10-tagged Cdc50p alone, as well as
co-expression plasmids allowing coordinated overexpression of
Bad-tagged Drs2p and His10-tagged Cdc50p, with the tags at
either the N-terminus or the C-terminus (with a Tobacco Etch
Virus (TEV) cleavage site between Drs2p and its tag, and with or
without a TEV cleavage site between Cdc50p and its tag), were
prepared as described previously [36,38]. When present, the
cleavage site was flanked by 2 glycines toward the tag and 4
glycines toward DRS2 or CDC50. Site-directed mutagenesis was
performed using the mega-primer method for D560N [39], or the
QuickChange site-directed mutagenesis system for E342Q.
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Functional complementation of Ddrs2 and Dcdc50
growth defect
W303.1b/GAL4 cells were transformed with the desired
plasmid according to the lithium-acetate/single-stranded carrier
DNA/PEG method [40]. Transformants were grown in a liquid
glucose-containing medium, S6A (0.1% (w/v) bacto casamino
acids, 0.7% (w/v) yeast nitrogen base, 2% (w/v) glucose, 20 mg/
mL adenine), for 24 hours at 28uC, and then serially diluted (to
0.02, 0.001, or 0.0002 OD600) with a galactose-containing
medium, S5A (0.1% (w/v) bacto casamino acids, 0.7% (w/v)
yeast nitrogen base, 2% (w/v) galactose, 20 mg/mL adenine),
supplemented with 1% (w/v) fructose to enable yeast growth at a
fair rate. 5-ml drops were spotted onto S5A plates (S5A medium +
2% (w/v) agar) supplemented with 1% (w/v) fructose, and
incubated at 20uC for 5–6 days or at 28uC for 2–3 days.
Expression of Drs2p-Bad and Cdc50p-His10 in Fernbach
flasks and yeast membrane preparation
Yeasts were transformed using the lithium-acetate/single-
stranded carrier DNA/PEG method [40]. Yeast cultures, clone
selection, recombinant protein expression and membrane prepa-
ration were performed as described previously [36,38]. Briefly,
yeast growth took place in a glucose-containing rich growth
medium at 28uC for 36 h, whereas expression of the proteins of
interest took place during an additional 18 h in the presence of
galactose at 18uC. Yeast cells were harvested by centrifugation,
washed with the appropriate buffer, and subsequently broken with
glass beads using a ‘‘Pulverisette 6’’ planetary mill (Fritsch). The
crude extract was then spun down at 1,000 g for 20 min at 4uC, to
remove cell debris and nuclei. The resulting supernatant was
centrifuged at 20,000 g for 20 min at 4uC, yielding S2 supernatant
and P2 pellet. The S2 supernatant was further centrifuged at
125,000 g for 1 h at 4uC. The resulting P3 pellet was finally
resuspended at about 30 mg/mL of total protein in HEPES-
sucrose buffer (20 mM HEPES-Tris pH 7.4, 0.3 M sucrose,
0.1 mM CaCl2). We estimated, by western-blotting, that the
proteins in the P3 fraction comprise about 3% of Drs2p [38].
Protein estimation and detection
In the membrane fractions, protein concentrations were
measured with the bicinchoninic acid procedure [41] in the
presence of 2% (w/v) SDS, using bovine serum albumin as a
standard. For the purified sample, its UV absorption was
measured at 280 nm, and converted into mg protein/mL on the
basis of the optical extinction coefficient predicted from the
sequences (www.expasy.org) for an equimolar mixture of Drs2p
and Cdc50p. According to this prediction, 1 mg/mL complex
should result in an OD of about 1.3 at 280 nm (for a 1-cm optical
path). Alternatively, purified Drs2p was compared with known
concentrations of Ca2+-ATPase from sarcoplasmic reticulum
membranes (SERCA1a) using Coomassie Blue stained gels.
Protein concentrations estimated by the two methods were similar.
For electrophoretic separation and identification, proteins were
loaded onto SDS-PAGE [42]. Proteins on the gels were then either
stained with Coomassie Blue (or silver nitrate), or transferred to
PVDF membranes. Detection of the biotinylated Drs2p-Bad was
performed using a Biotin probe (at a 1/25,000 dilution), detection
of total Drs2p was performed using an a-Drs2p antibody (at a 1/
5,000 dilution), and detection of Cdc50p-His10 was performed
using a Histidine probe (at a 1/2,000 dilution).
In a few cases, before their staining with Coomassie Blue,
proteins were visualized in-gel by light-induced specific chemical
modification of their Trp residues by a haloalkane, which makes
these modified Trp residues fluoresce at a convenient visible
wavelength [43,44].
Streptavidin resin samples were heated up to 90uC before
loading onto SDS-PAGE (this was not the case for other samples)
in order to allow dissociation of the strong SDS-resistant
interaction of avidin with the biotin bound to the Bad-tagged
Drs2p. This heating step is responsible for excessive formation of
Drs2p aggregates in the corresponding samples (data not shown).
Solubilization of P3 membranes and purification of the
Drs2p-Cdc50p complex
P3 membranes obtained after co-expression of Drs2p and
Cdc50p were diluted to 2 mg of total protein/mL (typically
120 mL) in ice-cold SSR buffer (Streptavidin Sepharose Resin
buffer, containing 50 mMMops-Tris at pH 7, 100 mM KCl, 20%
(w/v) glycerol and 5 mM MgCl2), supplemented with 1 mM
PMSF and an EDTA-free protease inhibitor mixture. DDM was
added at a final concentration of 2 mg/mL (i.e. at a DDM: protein
ratio of 1:1, w:w) and the suspension was stirred gently on a wheel
for 15 minutes at 4uC. Insoluble material was pelleted by
centrifugation at 100,000 g for 1 h at 4uC. The supernatant,
containing solubilized proteins, was applied onto a streptavidin-
Sepharose resin (typically 2.4 mL of previously washed resin per
120 mL of solubilized material) and incubated for 2 hours at 4uC
to allow binding of the Bad-tagged Drs2p to the resin. To
eliminate unbound material, the resin was washed four times with
three resin volumes of SSR buffer supplemented with 0.5 mg/mL
DDM and 0.025 mg/mL phosphatidylserine (POPS), in the
presence of 1 mM PMSF but in the absence of the SIGMA-
FAST protease inhibitor cocktail. Subsequent cleavage by TEV (at
0.03 mg/mL of total volume, resin + buffer) of the cleavage site
inserted between Drs2p and its Bad moiety allowed release of
Drs2p from the resin and simultaneous removal of the deca-
histidine tag on Cdc50p, by overnight incubation at 6uC.
For removal of the His6-tagged TEV protease, the streptavidin-
purified fraction was mixed with dry Ni2+-TED resin in a 500:1
Ni2+-TED:TEV ratio (w:w), and incubated for 45 minutes at 4uC
with gentle mixing on a wheel. A TEV-free fraction was recovered
by centrifugation at 500 g for 5 minutes.
For Size-Exclusion Chromatography (SEC)-HPLC, the strepta-
vidin-purified sample was first incubated with Ni2+-TED, to
remove the TEV protease, and then concentrated on YM100
ultrafiltration units (100 kDa cutoff). The YM100-concentrated
fraction (about 4 mg/mL) was briefly centrifuged (120,000 g for
10 minutes in a Beckman Coulter TLA 100.3 rotor) to get rid of
large aggregates. Aliquots (300 mL each) of this concentrated
supernatant were applied onto a TSK-3000SW column. Chro-
matography was performed at a flow rate of 1 mL/min, with the
SEC-HPLC mobile phase buffer corresponding to SSR buffer
without glycerol, supplemented with 0.5 mg/mL DDM and
0.025 mg/mL POPS. In order to limit unspecific adsorption of
the proteins, filters and columns had been rinsed with the
detergent- and lipid- containing buffer. The SEC purified fractions
were frozen in liquid nitrogen and stored at 280uC.
Standard soluble proteins (250 mL at 1 mg/mL) were used to
calibrate the column, and DDM-solubilized SERCA1a was used
as a control. For the latter purpose, SR membranes were diluted to
4 mg/mL in the mobile phase buffer supplemented with 1 mM
Ca2+ and 40 mg/mL DDM. After 10 minutes incubation at 20uC,
550 mL of this suspension was centrifuged at 120,000 g for
10 minutes in a TLA 100.3 rotor, and 500 mL of the supernatant
(solubilized material) was injected on the column.
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Analysis by Matrix-Assisted Laser Desorption/Ionization –
Time of Flight (MALDI-TOF) mass spectrometry of the
purified Drs2p-Cdc50p complex
Mass spectrometry analysis was first performed using a
procedure previously developed for detergent-solubilized and
SEC-purified intact membrane proteins [45,46]. One microliter
of the SEC purified sample was mixed with 3 mL of a saturated
solution of sinapinic acid in 30% acetonitrile and 0.3%
trifluoroacetic acid. One microliter of the mixture was loaded
into a MALDI-TOF spectrometer (Perseptive Biosystems, Voyag-
er DE-STR) equipped with a 337-nm nitrogen laser. Spectra were
obtained in linear mode using delayed extraction. Mass range was
from 30,000–200,000 Da (accelerating voltage of 25 kV). The
external standards used for calibration were: aldolase (39,211 Da)
and albumin (66,429 Da) (Proteomass MALDI-MS standards,
Sigma). Mass spectrometry was also used for unambiguous
identification of Drs2p and Cdc50p in the final purified sample,
as follows. SEC-purified samples were first loaded onto a 7% SDS-
PAGE, and the gel was stained with Coomassie Blue. Bands of
interest were excised manually and destained with a 50:50 mixture
of acetonitrile:0.1 M NH4HCO3, and then submitted to tryptic
digestion overnight at 37uC in 50 mM NH4HCO3. The superna-
tants were removed and peptides were extracted with 1%
trifluoroacetic acid (TFA) then with 60% acetonitrile containing
1% (v/v) TFA. The combined extracts were evaporated to 2 mL,
Figure 1. Co-expression in yeast and functional properties of C- or N-terminally tagged Drs2p and Cdc50p. (A) Functional
complementation of the temperature-sensitive phenotype of Ddrs2 and Dcdc50 yeast cells. Yeast cells, either wild-type, Ddrs2, or Dcdc50 mutants,
were transformed with plasmids bearing either DRS2 (WT or D560N) tagged with a sequence coding for Bad, or CDC50 tagged with ten histidines
(His10). Tags were inserted at the proteins C- or N-termini. Cells transformed with an empty vector (EV) were used as negative control. Serial dilutions
of yeast cells were spotted on plates and incubated at the restrictive temperature of 20uC. (B) Co-expression of C-terminally or N-terminally tagged
Drs2p and Cdc50p in P3 membranes, as analyzed by western-blotting. For detection using a Biotin or a Histidine probe (top and bottom gels,
respectively), 1.5 mg of total protein was loaded per lane and 1 mg total protein was used for detection with an a-Drs2p antibody (intermediate gel).
The biotin probe also weakly detected endogenous yeast proteins known to be biotinylated, Acc1p and Pyc1/2p (dashed arrows). Drs2p(t), truncated
form of Drs2p; Cdc50p(g), glycosylated forms of Cdc50p [36]; Cdc50p(c), core (unglycosylated) Cdc50p. (C) Phosphorylation from [c-
32P]ATP of P3
membrane fractions co-expressing the tagged Drs2p and Cdc50p proteins. Formation of the phosphoenzyme intermediate was measured in the
absence or presence of 1 mM vanadate (open bars and grey bars, respectively). (D) Turnover-dependent dephosphorylation in the presence of DDM
and POPS and in the presence (triangles) or absence (circles) of PI4P (see ‘‘Materials and Methods’’).
doi:10.1371/journal.pone.0112176.g001
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mixed with the same volume of half-saturated solution of a-cyano-
4-hydroxycinnamic acid in 50% acetonitrile, 0.3% TFA, and
submitted to MALDI-TOF mass spectrometry (Voyager DE-
STR). Spectra were acquired in positive-ion reflector mode with
delayed extraction, using six peptides of known masses as close
external calibration standards. Proteins were identified using the
Peptide Mass Fingerprint search program Mascot (http://www.
matrixscience.com/search_form_select.html) reducing the
NCBInr (release 20131113, 24201960 entries) to the Saccharomy-
ces cerevisiae species. Two missed cleavage sites and possible
oxidation of methionines were considered in searches.
Phosphorylation from [c-32P]ATP and turnover-
dependent dephosphorylation
Transient formation of the phosphoenzyme intermediate in the
Drs2p catalytic cycle was measured after incubation with
[c-32P]ATP followed by acid quenching, using a filtration protocol
(see e.g. [47]).
For experiments with P3 membranes (Figure 1C and 1D), 40-ml
samples at 0.5 mg/mL of total protein were pre-incubated on ice
in buffer A (100 mM KCl, 5 mM Mg2+ and 50 mM Mops-Tris at
pH 7), supplemented with 5 mg/mL DDM in the presence or
absence of 0.25 mg/mL POPS or 0.25 mg/mL PI4P. In some
cases, 1 mM orthovanadate was added. Phosphorylation was
triggered by addition of 0.5 mM [c-32P]ATP (at 0.25–1 mCi/
mmol) on ice (to avoid excessive ATP hydrolysis by Drs2p-
unrelated proteins in crude membranes), followed after 25 seconds
by acid quenching (typically 1 mL of 500 mM trichloroacetic acid
(TCA) + 30 mM H3PO4). Samples were left on ice for more than
half an hour after quenching, a period sufficient for aggregation of
the precipitated protein and therefore its retention by the filter
(this aggregation period was critical in the presence of detergent).
This was followed by filtration on either a glass fiber A/E filter or a
nitrocellulose GSWP filter, and careful rinsing with dilute acid
(50 mM TCA + 3 mM H3PO4). The kinetics of turnover-
dependent dephosphorylation were measured by first phosphor-
ylating the sample for 25 seconds on ice under the above
conditions and then chasing 32P from the phosphoenzyme by
transferring it into a tube pre-equilibrated at 37uC and containing
concentrated non-radioactive Mg-ATP (so that its final concen-
tration was 1 mM) for dephosphorylation during the desired time
period.
As purification of the Drs2p-Cdc50p complex allowed us to get
rid of most of the other ATP-hydrolyzing proteins present in crude
membranes, in this case, we could improve our phosphorylation
protocol compared with phosphorylation of Drs2p in membranes:
instead of allowing phosphorylation to proceed on ice and only
then transferring the sample at 37uC for dephosphorylation, we
could perform both phosphorylation and dephosphorylation at the
same temperature (30uC). The purified sample (typically 40 mL at
50–100 mg protein/mL), on ice, generally in SSR buffer in the
presence of detergent and exogenous lipids, was supplemented
with [c-32P]ATP and immediately transferred to 30uC for
phosphorylation, before classical acid quenching. Turnover-
dependent dephosphorylation was measured by first phosphory-
lating the sample up to steady-state under the above conditions
(typically 1 minute and a half) and then chasing 32P from the
phosphoenzyme by simply adding concentrated non-radioactive
Mg-ATP (so that its final concentration was 1 mM) for dephos-
phorylation during the desired time period at the same temper-
ature (30uC). In some cases, phosphorylation and dephosphory-
lation were measured in a KNG buffer (SSR buffer containing
66 mM NaCl and 33 mM KCl instead of 100 mM KCl), with no
obvious difference.
ATPase activity of purified samples
Pi released from ATP as a result of Mg-ATP hydrolysis was
deduced from colorimetric measurements, as described in [48]. In
some cases, the purified Drs2p-Cdc50p complex was first pre-
incubated with VOx, BeF3
2, or AlF4
2. Typically, the enzyme (at
about 50 mg Drs2p/mL) was supplemented with Mg-ATP
(generally 1 mM) and incubated at 30uC for various periods. At
the desired time point, 33 mL aliquots were withdrawn and
quenched with 17 mL of 10% SDS (plus antifoam). Pi in these
samples was subsequently revealed by adding ammonium-molyb-
date and zinc acetate at pH 5.0 [49], loading 96-well plates with
these samples and measuring the resulting blue color at 850 nm,
after 1–2 hours at room temperature. In some cases, ATPase
activity was measured at lower concentrations of ATP, with
0.1 mg/mL pyruvate kinase and 1 mM phosphoenolpyruvate as a
regenerating system. ATPase activities were measured in KNG
buffer or in SSR buffer, with no difference.
Throughout this paper, the average of two to three independent
data points (6 SD) is displayed.
Results
Co-expression in yeast and functional properties of C- or
N-terminally tagged Drs2p-Cdc50p complexes
In our previous work, we had chosen to introduce a Bad (Biotin
Acceptor Domain) tag and a His10 tag at the C-termini of Drs2p
and Cdc50p, respectively, for their overexpression in yeast [36].
However, the position of affinity tags on Drs2p has been suggested
to affect the activity of the resulting purified sample [30,31]. In the
present work, we therefore investigated in more detail the result of
an N-terminal location for these tags. We first looked at the ability
of the two types of constructs to restore normal growth phenotypes
in yeast strains deficient in one or the other of these proteins.
When Dcdc50 cold-sensitive yeast strains were transformed with
an expression plasmid bearing the sole CDC50 gene tagged at
either its 59 or 39 end, growth at 20uC was restored in both cases
(Figure 1A, bottom). When Ddrs2 cold-sensitive yeast strains were
transformed with a plasmid bearing the sole DRS2 gene, tagged at
either its 59 or 39 end, growth at 20uC was also restored in both
cases (Figure 1A, top), in agreement with a previous report in
which a different set of tags was used [30]. However, expression of
an inactive variant, bearing a mutation at the catalytic aspartate
(D560N), did not restore growth at 20uC. Thus, at this step, the
location of the tag did not appear to be critical, and we attempted
to overexpress both types of constructs using a co-expression
strategy where Drs2p and Cdc50p are both coded on the same
plasmid and where protein expression may be achieved at high
yeast cell densities [36].
After growth and expression, membranes were separated by
differential centrifugation, and fractions recovered after high-speed
centrifugation (P3) were submitted to SDS-PAGE. Use of a Biotin
probe revealed similar expression levels for the Bad-tagged Drs2p,
irrespective of the tag location. Endogenous proteins, e.g. Acc1p
and Pyc1/2p, known to be biotinylated in yeast, were also detected
(Figure 1B, top). For the construct with C-terminal tags, use of an
antibody directed against Drs2p (kindly provided by Dr Graham)
revealed two bands for Drs2p (Figure 1B, middle). This indicated
the presence of a truncated form of Drs2p (Drs2p(t)), lacking its C-
terminally tagged end (since this degraded form was not detected
by the Biotin probe). For this construct, use of a His probe also
indicated that a significant fraction of C-terminally tagged Cdc50p
was not glycosylated (Figure 1B, bottom). In contrast, for the
construct with N-terminal tags, truncation of Drs2p was signifi-
cantly less prominent and the relative contribution of the non-
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glycosylated Cdc50p was also reduced (Figure 1B, middle and
bottom). The fact that the truncated form of Drs2p was not
revealed by the Biotin probe using either N- or C-terminally
tagged constructs suggests that it results from degradation at both
its N- and C-termini.
Incidentally, note that having the Bad tag at the C-terminus of
Drs2p makes migration of the full-length Drs2p slightly slower
than when this tag is attached at the N-terminus (Figure 1B, top
and middle). Since subsequent Bad tag removal by TEV protease
results in virtually identical mobilities (data not shown), this implies
that the mere location of the tag affects the residual partial folding
of Drs2p in SDS. The fact that SDS only partially unfolds proteins
has already been documented for many other proteins [50]. The
same fact is observed for Cdc50p tagged with His10, although in
the opposite direction (Figure 1B, bottom). As subsequent tag
removal again results in identical electrophoretic mobilities for
both constructs (data not shown), this cannot be explained by
different glycosylation levels.
We then compared the functional properties of C- or N-
terminally tagged proteins. Two of these properties can be tested
with crude P3 membranes, namely the ability of Drs2p to become
phosphorylated and the rate of its dephosphorylation. In spite of
their different susceptibility to proteolysis, C-terminally and N-
terminally tagged Drs2p had a similar vanadate-sensitive phos-
phoenzyme level at steady-state (on a nmol 32P per mg total
protein basis) (Figure 1C). Moreover, the ability of phosphatidy-
linositol-4-phosphate (PI4P, a phosphoinositide previously shown
to be closely associated with the flippase activity of Drs2p
[16,31,36]) to stimulate dephosphorylation of Drs2p in the
presence of phosphatidylserine was also observed in both cases
(Figure 1D).
In the rest of this study, we focused on Drs2p-Cdc50p proteins
overexpressed using the N-terminally tagged constructs, because of
the lower extent of undesired proteolysis and of the more complete
glycosylation in this case.
Streptavidin-based single-step purification of Drs2p-
Cdc50p complex
In previous experiments performed with solubilized crude
membranes, we found that for protection of Drs2p from
detergent-induced irreversible inactivation, DDM at a moderate
concentration was one of the less deleterious detergents. DDM, for
instance, was superior to C12E8 or Triton X-100 [36], and our
purification procedure was therefore developed in the presence of
DDM. Purification of the Drs2p-Cdc50p complex was achieved
thanks to the strong interaction between the biotinylated Bad tag
of Drs2p and an avidin-based resin. Figure 2 shows typical data
obtained from N-terminally tagged constructs.
Solubilization of the Bad-tagged Drs2p and the His10-tagged
Cdc50p was almost complete (compare T and S lanes in
Figure 2B–2D). Most of the solubilized full-length Bad-Drs2p
bound to the streptavidin resin (compare S and FT lanes in
Figure 2B and 2C). In contrast, most of the solubilized truncated
Drs2p (Drs2p(t), Figure 2C) remained in the streptavidin flow-
through, in agreement with the above suggestion that the
truncated form of Drs2p has lost some of both its N- and C-
termini.
The resin only retained a limited number of proteins (R lane in
Figure 2A), primarily the full-length Bad-tagged Drs2p as well as
endogenous, biotinylated yeast proteins (R lane in Figure 2B and
2C). Remarkably, the resin also retained most of His10-tagged
Cdc50p (S, FT, and R lanes in Figure 2D), demonstrating that
thanks to our co-expression strategy the N-terminally tagged
Cdc50p is not produced in large excess compared with Drs2p, and
strongly suggesting, in addition, that the majority of the expressed
Cdc50p still interacts with Drs2p in the solubilized membranes.
Incubation of the resin with TEV protease (targeting a TEV
protease cleavage site inserted between Drs2p and its Bad tag)
made it possible to release Drs2p from the streptavidin beads.
Cleavage was essentially complete for Bad-tagged Drs2p (Fig-
ure 2B). This was accompanied by a slight increase in the
electrophoretic mobility of Drs2p (Figure 2A and 2C), while the
addition of TEV did not affect the endogenous yeast proteins also
retained by the resin. Cleavage was also complete for Cdc50p
(Figure 2D), again with a distinct change in its migration rate
(Figure 2A).
According to SDS-PAGE, the fraction eluted from the
streptavidin beads contained highly pure and tag-free Drs2p and
Cdc50p proteins, as well as some TEV protease (E lane in
Figure 2). Note that TEV remained bound to the streptavidin
resin to a significant extent (compare lanes RTEV and E in
Figure 2A and 2D), presumably due to binding of the protease,
after its proteolytic action, to the six residues that follow the resin-
bound N-terminal Bad tag (consistent with this, the amount of
TEV found in the eluate was larger when C-terminal constructs
Figure 2. Streptavidin-based purification of Drs2p and Cdc50p.
N-terminally Bad-tagged Drs2p and His10-tagged Cdc50p were purified
onto a streptavidin column, and eluted by TEV cleavage. (A) Coomassie
Blue stained 10% SDS-PAGE. (B, C, D) Immunodetection using a Biotin
probe, a a-Drs2p antibody and a Histidine probe, as indicated. T, total
membranes before solubilization; S, DDM-solubilized fraction; FT, flow-
through; R, Streptavidin Sepharose resin before addition of TEV; RTEV,
Streptavidin Sepharose resin after incubation with TEV for 16 h at 6uC;
E, fraction eluted from the resin after incubation with TEV. Drs2p(t),
truncated form of Drs2p; Cdc50p(g), glycosylated form of Cdc50p; His6-
TEV, N-terminally hexahistidine-tagged TEV.
doi:10.1371/journal.pone.0112176.g002
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were used, data not shown). In the final purified sample, the
concentration of Drs2p was about 0.2–0.3 mg/mL, yielding a total
of 1–2 mg purified Drs2p-Cdc50p for a 1-L yeast culture.
Final removal of the His6-tagged TEV protease was easily done
by incubating the streptavidin-purified eluate (Es) with a nickel
affinity resin, with only little non-specific loss of Drs2p and
Cdc50p (Figure 3A).
The fact that some Cdc50p is found in the fraction eluted from
streptavidin beads does not necessarily imply that all Drs2p
molecules are in complex with Cdc50p (see for instance [29] where
after a related purification attempt only 10% of purified Drs2p was
found to interact with Cdc50p). To determine how much of the
purified Drs2p is bound to its partner subunit, we co-expressed,
together with Drs2p, a version of Cdc50p lacking the TEV-
cleavage site between the His10 tag and Cdc50p. In that case,
purification on the streptavidin resin followed by TEV protease
action results in a Drs2p-His10Cdc50p sample (D-His10C), instead of
the previous tag-free Drs2p-Cdc50p sample (D–C). Subjecting this
D-His10C sample to the Ni
2+-TED step should allow the Ni2+-TED
resin to capture Drs2p molecules that are in complex with His10-
Cdc50p, while leaving Cdc50p-unbound Drs2p molecules in the
flow-through, and therefore should make it possible to quantify the
fraction of Drs2p molecules that are not associated with Cdc50p.
In such an experiment, only a small proportion of the His10-
tagged Cdc50p eluted from the streptavidin resin was recovered in
the Ni2+-TED flow-through (Figure 3A). Simultaneously, only a
small proportion of Drs2p was present in this flow-through,
indicating that the vast majority of Drs2p molecules are in tight
complex with Cdc50p. Estimation of the proportions of His10-
Cdc50p and Drs2p remaining in the Ni2+-TED flow-through was
performed by comparison with various dilutions of the initial
streptavidin eluate Es (Figure 3A, lanes Es/10 and Es/3), thus
avoiding possible errors due to non-linearity of the silver staining
procedure. It appears that the amount of Drs2p and Cdc50p in the
flow-through corresponds for both proteins to about 20% of the
initial total amount. This estimation was supported by western-
blot analysis of the same samples (Figure S1). Therefore, at least
80% of Drs2p is bound to Cdc50p in the ‘‘Es’’ purified fraction.
Note that in this experiment, the streptavidin eluate had been
diluted five-fold before interaction with Ni2+-TED. It is therefore
expected that the fraction of Cdc50p-bound Drs2p will be even
greater than 80% in the original purified fraction, as dilution
might lead to dissociation of the Drs2p-Cdc50p heterodimer.
In our purified material, there is therefore neither excess
Cdc50p (because of the Bad-dependent purification procedure),
nor excess Cdc50p-unbound Drs2p (Figure 3). The stoichiometry
of the complex itself was estimated using in-gel fluorescence after
modification of the protein Trp residues by a haloalkane [43,44].
Indeed, assuming that all protein Trp residues behave similarly in
the denaturing SDS-PAGE environment, the fluorescence inten-
sities associated with Drs2p and Cdc50p bands should reflect their
abundance. In-gel fluorescence quantification (Figure 3B, left)
indicated a 3-fold higher fluorescence intensity for Drs2p than for
Cdc50p, as expected for a 1:1 complex (mol:mol) on the basis of
the molecular weights and respective Trp contents of Drs2p
(154 kDa and 18 Trp) and Cdc50p (45 kDa for the non-
glycosylated protein and 6 Trp). Note that estimating this
stoichiometry on the basis of quantification of the Coomassie
Blue stained corresponding bands (Figure 3B, right) leads to a
similar 1:1 Drs2p:Cdc50p stoichiometry (mol:mol) in the strepta-
vidin eluate.
Further analysis by size-exclusion chromatography (SEC)
and mass spectrometry
After concentration on a 100 kDa centrifugal filter device, the
purified Drs2p-Cdc50p sample was analyzed by SEC on a TSK-
3000SW silica gel column, in the presence of DDM. Judging from
the elution positions of soluble standards (Figure 4A, top) or of
DDM-solubilized SERCA1a (110 kDa, 5.5 nm Stokes radius,
Figure 4A, bottom), the main elution peak (Figure 4A, bottom)
was found in the expected region. Its fairly symmetrical shape
indicated a good homogeneity and the initial sample apparently
contained only a very limited amount of aggregated material
eluting in the column void volume. Cdc50p eluted together with
Figure 3. The vast majority of Drs2p is in complex with Cdc50p, in a 1/1 stoichiometry. (A) Yeasts were transformed either with a regular
Bad-Drs2p/His10-Cdc50p construct (with N-terminal tags) or with a related construct in which the TEV cleavage site between the His10 tag and
Cdc50p had been omitted. This resulted, after streptavidin-based purification, in either the classical sample (D–C) or in a sample where Cdc50p
remains tagged with His10 (D-His10C). For both samples, the streptavidin-eluted fractions were diluted 5-fold (to about 70 mg/mL) in KNG buffer
supplemented with 1 mg/mL DDM, 0.025 mg/mL PS and 0.025 mg/mL PI4P, and 300 mL of each diluted sample was mixed with 5 mg of dry Ni2+-TED
resin (previously washed with the dilution buffer) and incubated on a wheel for 45 minutes in the cold room. Initial diluted samples (Es), and
unbound material (FT), were loaded onto a 10% SDS-PAGE and stained with silver nitrate. For D-His10C, the Es sample was further diluted 3-fold and
10-fold and aliquots (Es/10 and Es/3) were loaded for comparison with the FT sample. (B) 2.5 mg and 0.5 mg of streptavidin-purified Drs2p-Cdc50p
complex were loaded onto a haloalkane-containing 4–20% gradient gel for both in-gel fluorescence analysis (left, Fluo) and subsequent Coomassie
Blue staining of the same gel (right, CB).
doi:10.1371/journal.pone.0112176.g003
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Drs2p, as judged from SDS-PAGE analysis of eluted fractions,
confirming the tight association of the two protein subunits
(Figure 4B).
We also submitted the SEC-purified sample to complementary
analysis by MALDI-TOF mass spectrometry, without any
preliminary trypsinolysis. As displayed in Figure 4C, only a few
peaks showed up, and they were in the expected range of
molecular masses. One, presumably corresponding to the singly
charged form of Drs2p, had an m/z at 154,324 Da, and another
one, presumably corresponding to the same peptide with two
positive charges, had an m/z at 77,233 (77,23362 = 154,466).
154,324 and 154,466 are close to the theoretical mass expected for
recombinant Drs2p, namely 154,050 Da (including what is left
from the N-terminally located TEV cleavage site (one glycine),
plus four glycines used as a linker between the TEV cleavage site
and the N-terminus of Drs2p). A major peak also showed up with
an m/z at 52,266, presumably corresponding to the monoionized
form of glycosylated Cdc50p (since the molecular mass of
recombinant non-glycosylated Cdc50p is only 45,136, again
including the linker glycines). The species detected at m/z of
,103,524 presumably corresponds to dimers (52,26662 =
104,532) of this glycosylated Cdc50p. The SEC-purified sample
was also treated with trypsin, which allowed identification of
several peptides corresponding to Drs2p and Cdc50p (data not
shown).
The purification procedure described here allows us to recover a
sample which contains Drs2p and Cdc50p in complex, most likely
in a 1:1 stoichiometry. Starting from 240 mL of yeast P3
membranes at 2 mg protein/mL (prepared from 2.4 L of yeast
culture), we recovered 4 mL of a SEC-purified fraction containing
about 0.6 mg.mL21 of protein (as estimated from its absorbance at
280 nm), i.e. about 2.4 mg of purified Drs2p-Cdc50p (out of
which ,1.8 mg is Drs2p). We could therefore recover about 1 mg
of SEC-purified complex per liter of yeast culture, with an
Figure 4. Size-exclusion chromatography and mass spectrometry analysis of the purified Drs2p-Cdc50p complex. (A) Top: calibration
of the TSK-3000SW silica gel column with gel filtration standards. The elution volume of Thyroglobulin corresponds to the dead volume (V0), while
Vitamin B12 is eluted at a volume close to the total volume (Vt). Bottom: size-exclusion chromatography profile of the streptavidin-purified Drs2p-
Cdc50p complex (continuous line). The streptavidin-purified and Ni2+-TED-treated fraction was first concentrated on YM100 filters and 300 mL was
then injected on the column. Fractions 1–4 were collected. The dotted line shows the behavior of a control DDM-solubilized SR SERCA1a sample
(500 mL at 4 mg/mL was injected). (B) Analysis of the collected fractions on an 8% Coomassie Blue stained SDS-PAGE. (C) An aliquot of the SEC-
eluted sample was submitted to mass spectrometry analysis. Spectra were acquired on a range of m/z values from 30,000 to 200,000.
doi:10.1371/journal.pone.0112176.g004
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estimated purification yield of 13% assuming 3% Bad-Drs2p
enrichment in the initial P3 fraction (see [36]).
The purified Drs2p-Cdc50p complex retains a sub-
micromolar apparent affinity for phosphorylation from
ATP, as well as PI4P-stimulated dephosphorylation
At this step, we turned to functional characterization, and first
asked whether the purified Drs2p-Cdc50p complex has retained
the phosphorylation and dephosphorylation properties previously
documented in crude membranes (Figure 1D and [36]). These
analyses were generally performed with the streptavidin-purified
Drs2p-Cdc50p complex (without SEC-HPLC), but we verified
that this additional step left these properties essentially unchanged
(data not shown).
Firstly, the purified Drs2p-Cdc50p complex is efficiently
phosphorylated from [c-32P]ATP, up to a forty-fold higher level
than solubilized crude membranes (about 1.6 nmol/mg in
Figure 5A, compared with 0.04 nmol/mg in Figure 1D). We also
found that the observed phosphorylation level was already nearly
saturated at a Mg-ATP concentration of 0.5 mM (Figure 5A). This
sub-micromolar apparent affinity for Mg-ATP showed up both in
the absence and presence of PI4P, whereas in the presence of
vanadate the apparent affinity for ATP was much lower
(Figure 5B).
Secondly, we found that after a chase with non-radioactive Mg-
ATP in the presence of DDM and PS only, slow dephosphory-
lation of the purified Drs2p took place (Figure 5C). Similar to the
situation for Drs2p in crude membranes, this dephosphorylation
was accelerated by the additional presence of PI4P, with an
estimated decay half-time of about 3–4 minutes (Figure 5D). The
purified Drs2p-Cdc50p complex has therefore retained the
phosphorylation and dephosphorylation properties previously
demonstrated in native or solubilized crude membranes. It is of
note that in the presence of PI4P, maximal phosphorylation was
soon followed by a decline in the phosphoenzyme level even in the
absence of any ATP chase (Figure 5D): the more transient
phosphorylation level observed in the presence of PI4P, compared
to that in its absence (Figure 5C), is qualitatively consistent with
the idea that a faster rate of dephosphorylation in the presence of
PI4P results in a faster exhaustion of [c-32P]ATP (here used at a
total concentration of only 0.5 mM).
The WT Drs2p-Cdc50p complex exhibits a PI4P-
dependent ATPase activity, while for inactive constructs,
only PI4P-independent activity is observed
As most of the ATP hydrolyzing contaminants in yeast
membranes have presumably been removed during purification,
the ATPase activity of the Drs2p-Cdc50p complex could be
examined. At 30uC, we were indeed able to detect ATPase
activity, and also to reveal, for the WT enzyme, its strong
dependence on PI4P (Figure 6B).
We then purified inactive variants, to verify that this PI4P-
stimulated ATPase activity was indeed related to Drs2p-Cdc50p.
We first generated a Drs2p version mutated on the catalytic
aspartate (D560N variant) and co-expressed it together with
Cdc50p (DD560N-C). We could not detect any PI4P-dependent
ATPase activity for the DD560N-C complex (Figure 6C), but in this
case, Drs2pD560N and Cdc50p had both been expressed and
therefore purified at very low levels (ATPase activities were
measured at relative protein concentrations identical to those
illustrated on the gels in Figure 6A). However, the PI4P-
independent ATPase activity observed for the D560N variant
was fairly similar to that of the WT, despite the very large
difference in Drs2p concentrations. This suggests that most of this
PI4P-independent ATPase activity is not related to the Drs2p-
Cdc50p complex.
To rule out the possibility that the PI4P-dependent activity
could be mediated by a minor but very active co-purified
contaminant, rather than by Drs2p itself, we looked for another
mutation that would make Drs2p inactive, without compromising
its interaction with Cdc50p. Along those lines, it has been reported
that the E342Q mutation of the DGET motif (corresponding to
TGES in P2-ATPases), which is known to be critical for
dephosphorylation in P-type ATPases (including P4-ATPases,
see [25]), preserves the Drs2p-Cdc50p interaction [29]. Upon
Figure 5. Phosphorylation and dephosphorylation properties
of the purified Drs2p-Cdc50p complex. (A) Time course of ATP-
dependent phosphorylation of the purified Drs2p-Cdc50p complex at
various concentrations of [c-32P]ATP. The streptavidin-purified and Ni2+-
TED-treated sample, diluted to about 50 mg/mL in SSR on ice in the
presence of 1 mg/mL DDM and 0.05 mg/mL POPS, was supplemented
with [c-32P]ATP (typically 4 mL of concentrated ATP was added to 40 mL
enzyme) and brought to 30uC for various periods before acid
quenching and filtration. (B) ATP-dependence of the maximal
phosphorylation level, in the absence (open circles) or presence (open
triangles) of PI4P at 0.025 mg/mL. In some cases, the purified sample
had been first pre-incubated with 1 mM vanadate (grey symbols). (C
and D) The streptavidin-purified sample (here before Ni2+-TED
treatment, and diluted to about 60 mg/mL) was supplemented with
0.5 mM [c-32P]ATP in the absence (C) or presence (D) of PI4P, and
phosphorylation at 30uC was measured (white symbols). Grey symbols
refer to experiments performed in the presence of vanadate. To trigger
ATP-induced chase of the radioactively-labelled phosphoenzyme, 1 mM
non-radioactive Mg-ATP was added after 1.5 minute (black symbols, in
the absence of vanadate).
doi:10.1371/journal.pone.0112176.g005
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expression in yeast membranes, the Drs2pE342Q variant could not
restore growth of Ddrs2 cells at low temperatures (Figure 6D),
suggesting that the mutation indeed makes Drs2p inactive. After
co-expression of such a Drs2pE342Q variant with Cdc50p, the
Drs2pE342Q-Cdc50p complex could be purified at wild-type levels
(Figure 6A). Although its activity in the absence of PI4P was of the
same order of magnitude as those observed for the other
complexes, no PI4P-dependent activity could be detected for this
inactive complex (Figure 6E).
To further strengthen our conclusions, we also purified wild-
type Drs2p after its expression in the absence of Cdc50p
(Figure 6A). We knew that in the absence of Cdc50p, Drs2p was
not able to undergo phosphorylation from [c-32P]ATP [29,36].
Consistent with expectation, purified Drs2p did not exhibit any
detectable PI4P-dependent ATPase activity (Figure 6F), while the
ATPase activity measured in the absence of PI4P was similar to
that found for WT ATPase. As an additional control, we also
purified Cdc50p alone, using a Bad-tagged version of Cdc50p.
Again, that purified sample displayed a background PI4P-
independent ATPase activity but no detectable PI4P-dependent
ATPase activity (data not shown).
From these results we conclude that the PI4P-independent
ATPase activity in the purified samples is most probably due to a
contaminant with a substantial specific activity, given that no
Figure 6. ATPase activities of various streptavidin-purified samples. (A) Coomassie Blue staining after SDS-PAGE of purified wild-type
complex (DWT-C), D560N variant (DD560N-C), E342Q variant (DE342Q-C), and wild-type Drs2p expressed alone. (B–C and E–F) The ATPase activity of the
same samples (after 5-fold dilution resulting in about 60 mg/mL Drs2p in the case of the WT enzyme) was measured at 30uC in a KNG medium
supplemented with 1 mg/mL DDM, 0.025 mg/mL PS and 1 mM Mg-ATP, in the absence (circles and dashed lines) or presence (triangles and
continuous lines) of 0.025 mg/mL PI4P. The dotted line in panels C-F is given for easier comparison with results for WT. (D) Functional
complementation of the temperature-sensitive phenotype of Ddrs2 yeast cells. Yeast cells, either wild-type or Ddrs2, were transformed with plasmids
bearing DRS2 tagged at its 59 end, either WT or E342Q. Cells transformed with an empty vector (EV) were used as negative control. Serial dilutions of
yeast cells were spotted on plates and incubated at the restrictive temperature of 20uC.
doi:10.1371/journal.pone.0112176.g006
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contaminating band could be visualized on SDS-PAGE (Fig-
ure 6A). In contrast, the PI4P-dependent ATPase activity can be
unambiguously attributed to the wild-type Drs2p-Cdc50p com-
plex. Consistent with this, it is worth mentioning that after SEC-
HPLC, the PI4P-independent activity was reduced compared to
the PI4P-dependent activity, consistent with reduction of contam-
inants during SEC-HPLC (data not shown).
Note that in the experiments displayed in Figure 6B, about
180 mM Pi was produced in 100 min for a Drs2p concentration
estimated to be 60 mg/mL, implying a specific activity of about
0.03 mmol.min21.mg21 (at 0.025 mg/mL PS and 0.025 mg/mL
PI4P). This activity varied somewhat from batch-to-batch, up to 2-
fold.
Characterization of the PI4P-dependent ATPase activity
of the purified Drs2p-Cdc50p complex
Now focusing in more detail on the PI4P-dependent ATPase
activity of WT Drs2p-Cdc50p complex, this activity appeared to
have a number of very attractive features. In the presence of
1 mg/mL DDM and 0.05 mg/mL POPS, it was stimulated by
PI4P to a high degree and the apparent [PI4P]1/2 was of the order
of a few mg/mL (or a few mM) only (Figure 7A) (since PI4P does
not distribute equally in the total volume but is mainly found in
mixed micelles together with DDM, here used at 1 mg/mL, this
apparent affinity is more significantly expressed in terms of PI4P/
DDM ratio: [PI4P]1/2 was of the order of a few mg of PI4P per mg
of DDM). Compared with this high affinity, the apparent affinity
for PS (Figure 7A), in the presence of a nearly saturating
concentration of PI4P (0.025 mg/mL), was poorer: [PS]1/2 was
certainly higher than 20 mg/mL. Note that since purification was
performed in the presence of PS, the assay medium contained in
all cases ,80 mg/mL of residual PS derived from the purification
procedure, hence the uncertainty about the activity in the total
absence of PS.
For testing the individual effect of each lipid, we therefore
omitted PS during the final steps of the purification procedure (i.e.
the washing steps which precede TEV addition, as well as the
subsequent elution), to better control the amount of PS in the final
purified sample. Under the conditions of the present relatively
rapid purification protocol, the absence of PS was not deleterious
and the enzyme could be purified in a very similar manner (inset to
Figure 7B). In the absence of PI4P (Figure 7B), the ATPase
activity was independent of the addition of POPC or POPS. In the
presence of PI4P (Figure 7B), POPC only had a slightly
stimulating effect, POPE had a larger one, and PS had the largest
stimulating effect, irrespective of its fatty acyl chain (POPS or
DMPS). Addition of PI4P alone to the purified sample had a small
effect per se, possibly due to residual PS strongly bound to the
purified complex.
Using the enzyme purified in the presence of PS throughout, the
apparent affinity for Mg-ATP was about 10 mM in the presence of
PI4P (Figure 7C and 7D). This apparent affinity, deduced from
overall ATPase measurements, is poorer than the sub-micromolar
apparent affinity deduced from steady-state phosphorylation
measurements (Figure 4), but for P-type ATPases this is a quite
common observation, because of the modulatory effect of ATP on
other steps of the functional cycle besides the phosphorylation step
itself [51,52]. Note that an apparent affinity of 10 mM for Mg-ATP
for the present purified sample is far stronger than the one
previously reported for Drs2p (1.5 mM in [30]).
We also tested the sensitivity to orthovanadate and metallo-
fluorides of the PI4P-dependent activity of our purified Drs2p-
Cdc50p sample. These classical inhibitors of P-type ATPases did
affect the ATPase activity of Drs2p-Cdc50p, but vanadate had a
rather poor KI, in the millimolar range (Figure 7E). In contrast,
BeF3
2 and AlF4
2, which are known to be reactive with E2-like
states of other P-type ATPases (e.g. [35]), significantly inhibited
the ATPase activity of Drs2p-Cdc50p for concentrations as low as
150 mM (Figure 7F).
PI4P protects the purified Drs2p-Cdc50p complex from
irreversible denaturation under various conditions
We previously found that during overnight incubation at 4uC of
P3 membranes solubilized at a high DDM to protein ratio (10:1,
w:w), a ratio likely to result in delipidation of the solubilized
proteins, Drs2p slowly lost its ability to get phosphorylated [36].
We now examined the stability of the streptavidin-purified
complex to identify optimal conditions for future studies (e.g. for
crystallization).
When incubation in the presence of DDM took place at 30uC,
the Drs2p-Cdc50p complex lost its phosphorylation ability very
rapidly (over minutes) in the absence of PS (open circles in
Figure 8A). The presence of PS exerted significant, but only
partial, protection (Figure 8A). DOPC was even less effective than
POPS (data not shown). In contrast, we found that the presence of
PI4P afforded complete protection at 30uC, and this was in fact
true both in the presence and the absence of POPS (Figure 8A).
At 20uC, PS alone was sufficient to make the Drs2p-Cdc50p
complex fairly stable over 3 hours in the presence of DDM
(Figure 8B), and additional PI4P was therefore not needed. This
was however no longer the case in the presence of the more
deleterious C12E8, and in this case the additional presence of PI4P
afforded significant stabilization (Figure 8C). Note that in this
experiment a significant amount of residual DDM was left
together with C12E8, resulting in a C12E8/DDM ratio of about
1/1 (w/w).
At 4uC, PI4P allowed Drs2p to remain perfectly stable in the
same C12E8/DDM/PS environment (Figure 8D), just as stable as
in the presence of PS alone in DDM (Figure 8D).
Protection of the Drs2p-Cdc50p complex by PI4P, either in the
presence of C12E8 or in DDM at a temperature higher than 4uC,
was also checked by measuring the residual ability of the complex
to hydrolyze ATP in the presence of PI4P (not only to get
phosphorylated from it). The residual ATPase activities were
consistent with the residual phosphorylation levels with respect to
the ability of PI4P, in addition to POPS, to protect the protein
from DDM- or C12E8-induced damage. In fact, the ATPase
activity was even slightly more resistant to inactivation than
phosphoenzyme formation (Figure S2). This strong stabilizing
effect of PI4P, here demonstrated for both aspects of Drs2p-
Cdc50p function, should be of major help for future crystallization
of the complex.
Discussion
In this study, we devised a robust procedure for the purification
in high-yield of a yeast lipid flippase, the Drs2p-Cdc50p complex.
Because Cdc50 proteins appear to be closely associated with P4-
ATPase maturation and function [14,29,53,54,55,56,57,58], we
previously chose to clone DRS2 and CDC50 genes into the same
expression plasmid. The purification procedure described here
represents an additional major step forward for obtaining enough
purified material for future structural and functional character-
ization of the Drs2p-Cdc50p complex.
This procedure is relatively simple and efficient, as most other
yeast proteins are eliminated by a single step affinity chromatog-
raphy (Figure 2), and, most importantly, as it keeps associated
(Figure 3) the two co-expressed partners of the complex in what
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appears to be a 1:1 ratio (previous reports on the purification of
Drs2p or other P4-ATPases have not all been optimal in this
regard [29,30,57,59]). The reason why the present protocol yields
a purified fraction that mostly contains Drs2p and Cdc50p in
complex might be related to the fact that unlike previous attempts,
we here chose to clone DRS2 and CDC50 genes on a single co-
expression plasmid, rather than on two different plasmids, with
both genes under the control of the same galactose-inducible
promoter. By circumventing a frequent behavior of 2 m-based
plasmids, namely an unequal number of plasmids in each cell, our
Figure 7. Lipid-dependence and Mg-ATP-dependence of the ATPase activity of the purified sample. (A) The ATPase activity of the
streptavidin-purified and Ni2+-TED-treated sample, diluted to about 50 mg/mL, was measured at 30uC in SSR buffer supplemented with 1 mMMg-ATP
and 1 mg/mL DDM, as well as with PI4P at various concentrations in the additional presence of 0.05 mg/mL POPS (circles), or with POPS at various
concentrations in the additional presence of 0.025 mg/mL PI4P (triangles). (B) The ATPase activity of a sample purified in the absence of PS (and
diluted to about 100 mg/mL) was measured at 30uC in KNG buffer supplemented with 1 mg/mL DDM, 1 mM Mg-ATP, and various lipids (all at
0.05 mg/mL), in the absence (hatched bars) or presence (open bars) of 0.025 mg/mL PI4P. Inset: Coomassie Blue staining of this purified sample after
SDS-PAGE. (C) The same purified sample as the one for Panel A was used, but in this case the activity was measured at various concentrations of Mg-
ATP, in the additional presence of an ATP-regenerating system (and in the presence of 1 mg/mL DDM, 0.05 mg/mL POPS and 0.025 mg/mL PI4P). (D)
Plot of the results of the experiment displayed in (C) for determination of the apparent affinity for ATP, in the presence (open triangles) or absence
(open circles) of PI4P. [Mg-ATP]1/2 is the concentration of ATP necessary to reach half of the maximal velocity. (E and F) After a 1-hour pre-incubation
period on ice either with various VOx concentrations (E) or with various BeF3
2 or AlF4
2 concentrations (F), the ATPase activity of Drs2p-Cdc50p was
measured at 30uC in SSR buffer supplemented with 1 mg/mL DDM, 0.05 mg/mL POPS, and 1 mM ATP, in the absence (grey bars) or presence (open
bars), of 0.025 mg/mL PI4P.
doi:10.1371/journal.pone.0112176.g007
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co-expression system has probably favored a balanced expression
of Drs2p and Cdc50p in yeast cells. Our choice of DDM may also
have helped keeping the complex intact during the purification
procedure.
The purified proteins have the expected sizes, and the very
marginal fraction of aggregated protein can be successfully
removed by size-exclusion chromatography (Figure 4). The
purified complex retains the functional phosphorylation and
dephosphorylation properties that can be measured in crude
membranes before their solubilization (Figure 5 vs Figure 1).
Importantly, the ATPase activity of the purified sample is greatly
stimulated by the simultaneous presence of PS and the phospho-
inositide lipid PI4P (Figure 7), as previously reported [31]. In fact,
only the PI4P-dependent ATPase activity can be specifically
attributed to active Drs2p-Cdc50p complex, as mutations of either
the D560 catalytic aspartate in the phosphorylation motif, or the
E342 residue in the DGET motif – whose homologous mutation
results in an inactive ATPase in other P-type ATPases [25,60] –
abrogated the PI4P-stimulated activity but left a significant PI4P-
independent activity (Figure 6). On the basis of a recent study by
Graham’s laboratory suggesting that PI4P relieves at least part of
the auto-inhibition of Drs2p by its C-terminus, whereas it has a
more limited impact on C-terminally truncated forms [31], this
would be consistent with our purified fraction mainly containing
full-length Drs2p together with Cdc50p. The fraction eluted after
affinity chromatography also contains a few contaminant proteins
(e.g. those contributing to PI4P-independent activity), but they are
present in very small quantities (Figure 3A and Figure 6A). These
contaminants can be further reduced by SEC-HPLC, with a
concomitant reduction of the ratio of PI4P-independent to PI4P-
dependent ATPase activities.
The purified Drs2p-Cdc50p complex has a high affinity for its
regulator, PI4P (Figure 7). It also retains a high affinity for Mg-
ATP, with sub-micromolar apparent affinity with respect to
phosphoenzyme formation and micromolar apparent affinity with
respect to overall ATPase activity (Figure 5 and Figure 7). These
high apparent affinities for PI4P and Mg-ATP speak in favor of
the structural integrity of the Drs2p-Cdc50p complex. The poorer
apparent affinity for ATP previously described for purified Drs2p
(about 1.5 mM, see [30]) might be related to the use in that case of
C12E9 for solubilization, as in our hands the related C12E8
detergent proved rather inactivating (Figure S2 and [36]).
Alternatively, the discrepancy might be due to the presence of
some Cdc50p-unbound Drs2p in that study [30]. The poor
apparent potency of vanadate which we measured for inhibition of
the PI4P-dependent ATPase activity (Figure 7E) could at first
seem puzzling, but it might simply be taken as an indication that
during turnover in the presence of a large ATP concentration
(1 mM for ATPase activity measurements), most of the Drs2p-
Cdc50p complex resides in a state which is not much sensitive to
vanadate. A similar situation has been described for well-known P-
type ATPases (e.g. SERCA1a), because vanadate is thought to
recognize efficiently only certain conformations of the pump
during its turnover [45,61,62]. Furthermore, our purified sample
displayed an apparent affinity for vanadate in the micromolar
range with respect to phosphoenzyme formation (data not shown),
which is a value similar to that previously described for Drs2p
embedded in yeast membranes [36].
At this point, it is useful to discuss another remarkable result of
our experiments, namely the fact that the ATPase activity we
measured for purified Drs2p-Cdc50p was rather slow, typically
around 30–60 nmol.mg21.min21 at 30uC in the presence of
1 mM Mg-ATP, 1 mg/mL DDM, 0.025 mg/mL POPS and
0.025 mg/mL PI4P, and in fact slower than previously reported
[30,31]. This slow rate goes along with the previously noted very
slow Drs2p dephosphorylation measured after an ATP chase,
including in crude membranes ([36] and this study). Compared
with ATP hydrolysis and transport rates measured for well-known
P2-type transport ATPases, e.g. the Na+,K+-ATPase or SERCA1a
under similar conditions, these are very slow rates. For example,
under similar conditions (except for the absence of PI4P), we
measured an activity for SERCA1a at least ten-fold higher than
that of Drs2p-Cdc50p (data not shown). Another P4-type ATPase,
Figure 8. Protection of the purified Drs2p-Cdc50p complex
from irreversible denaturation. (A) The streptavidin-purified
sample (before treatment with Ni2+-TED) was diluted to 17.5 mg/mL
into KNG buffer at 30uC, supplemented with 1 mg/mL DDM, in the
absence (circles) or presence (triangles) of 0.025 mg/mL POPS, and in
the absence (open symbols) or presence (closed symbols) of 0.025 mg/
mL PI4P. After various periods of incubation, residual phosphorylation
was measured 1 min after addition of [c-32P]ATP. (B–D) The
streptavidin-purified sample (here after treatment with Ni2+-TED), was
pre-incubated for various periods at about 150 mg/mL in SSR buffer
supplemented with various detergents and lipids at different temper-
atures, before dilution with two volumes of DDM- and lipid-containing
SSR buffer, such that in all cases final conditions included 1 mg/mL
DDM, 0.05 mg/mL POPS, and 0.025 mg/mL PI4P. 0.5 mM [c-32P]ATP was
added and the residual ability of the sample to get phosphorylated was
measured (after 1.5–2 min at 30uC). Pre-incubation conditions: (B) 20uC,
0.75 mg/mL DDM + 0.025 mg/mL POPS, in the absence (open triangles)
or presence (closed triangles) of 0.025 mg/mL PI4P. (C) 20uC, 0.75 mg/
mL DDM + 0.75 mg/mL C12E8 + 0.025 mg/mL POPS, in the absence
(open squares) or presence (closed squares) of 0.025 mg/mL PI4P. (D)
On ice, 0.75 mg/mL DDM + 0.75 mg/mL C12E8 + 0.025 mg/mL POPS in
the presence of 0.025 mg/mL PI4P (closed squares), or 0.5 mg/mL DDM
+ 0.025 mg/mL POPS alone (open triangles).
doi:10.1371/journal.pone.0112176.g008
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the bovine ATP8A2, was recently described to hydrolyze ATP at
rates close to 150 mmol.mg21.min21 at 37uC and 7.5 mM Mg-
ATP [26].
This raises a number of issues. If the true activity of our purified
Drs2p-Cdc50p complex is slow, could it be that it lacks a critical
P4-ATPase co-factor? For instance, whether Gea2p, which has
been shown to associate with Drs2p [15] and to play a role in the
Drs2p flippase machinery [16] co-purifies with the Drs2p-Cdc50p
complex may be worth investigating, although we do not expect
this to be a critical component as no significant stimulation of the
Drs2p activity by the Gea2p Sec7 domain was observed [31]. We
think that it is reasonable to anticipate that the Drs2p-Cdc50p
complex indeed has a fairly slow turnover rate (as suggested by its
rates of dephosphorylation and ATP hydrolysis measured here),
because in yeast trans-Golgi or secretory vesicle membranes, PS
seems to be transported quite slowly, over hours [63,64], i.e. at a
rate probably consistent with a slow rate of ATP hydrolysis, at least
assuming a coupling ratio of,1 between ATP hydrolysis and lipid
transport. A slow transport with a fast ATPase activity would in
fact imply poor coupling.
Conversely, the reason why other P4-type flippases, like bovine
ATP8A2 found for example in membranes of retinal photorecep-
tors, hydrolyze ATP and get dephosphorylated during turnover
extremely rapidly (the reported hydrolysis rate of 150 mmol.mg21.-
min21 [25,26] implies a turnover number around 350 s21, i.e. that
lipid transport occurs within milliseconds) is unclear. It was
previously suggested [36,65] that perhaps rapid active transport of
lipid was needed in specific types of membranes (like the one from
which ATP8A2 originates) to efficiently counterbalance rapid
dissipation of lipid asymmetry by ATP-independent flippases
located in those membranes (e.g. opsin in retinal photoreceptors
[65]). However, flipping of lipids by opsin is thought to occur at a
rate faster than 10,000 per second [65,66], making it rather
unlikely that ATP8A2 can efficiently counteract randomization of
lipids by opsin. Therefore, the question remains open.
From a mechanistic or molecular point of view, it might be
speculated that the slow activity of Drs2p could be due to auto-
inhibition by its C-terminal and/or N-terminal extensions (as often
observed in other P-type ATPases). The existence of such auto-
inhibition of Drs2p by its C-terminal end has been suggested
recently [31]. Auto-inhibition by C- or N-terminal extensions
might even be a conceivable explanation for the fact that our
purified Drs2p enzyme is significantly slower than Drs2p purified
in other labs. Both in our hands (Figure 1A) and in the Graham
lab, for instance, various types of truncations of the overexpressed
Drs2p have been detected. Assuming that some very limited (and
thus undetectable) truncation occurs, to a variable extent, and that
this truncation partly relieves the auto-inhibition of Drs2p, this
might significantly influence the overall ATPase activity of the
purified Drs2p-Cdc50p complexes, both in our lab (where we
found up to 2-fold variability in ATP hydrolysis rates) and in other
labs. Future studies aiming at deciphering the Drs2p-Cdc50p
transport mechanism should help to resolve this apparent
discrepancy.
Finally, this work also presents a finding which might be of
major significance. A critical parameter for successful crystal-
logenesis of a membrane protein is the choice of the detergent to
be used, because among other effects it influences the stability of
the protein [67] and for several P-type ATPases, C12E8 has proven
superior to other detergents in terms of crystal growth [20,21,22].
Therefore, our finding that phosphoenzyme formation from ATP
and the overall ATPase activity of Drs2p-Cdc50p are strongly
stabilized by PI4P in the presence of both DDM or C12E8
(Figure 8) is an important step towards obtaining well-diffracting,
functionally-relevant crystals of a particular and presumably
important conformation of the Drs2p-Cdc50p complex.
Supporting Information
Figure S1 The vast majority of Drs2p is in complex with
Cdc50p, as analyzed by western-blotting. The same
samples as those in Figure 3 were loaded onto a 10% SDS-PAGE
and the gel was probed with a a-Drs2p antibody or a Histidine
probe. For D-His10C, the Es sample was further diluted 3-fold and
10-fold (Es/10 and Es/3) and aliquots were loaded for comparison
with the FT sample.
(TIF)
Figure S2 Protection by PI4P of the ATP hydrolysis
ability of the purified Drs2p-Cdc50p complex. The
streptavidin-purified sample (after treatment with Ni2+-TED),
was pre-incubated for various periods at ,150 mg/mL in SSR
buffer supplemented with various detergents and lipids and at
different temperatures. These samples were then diluted with two
volumes of DDM- and lipid-containing SSR buffer, such that in all
cases final conditions included 1 mg/mL DDM, 0.05 mg/mL
POPS, and 0.025 mg/mL PI4P. The ATPase activity was then
measured at 30uC, in the presence of 1 mM Mg-ATP. Pre-
incubation conditions: 20uC, 0.75 mg/mL DDM + 0.025 mg/mL
POPS, in the absence (open triangles) or presence (closed triangles)
of 0.025 mg/mL PI4P; 20uC, 0.75 mg/mL DDM + 0.75 mg/mL
C12E8 + 0.025 mg/mL POPS, in the absence (open squares) or
presence (closed squares) of 0.025 mg/mL PI4P.
(TIF)
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